Bioxcel Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $57k | 19k | 2.95 |
| 2023-09-30 | $336k | 133k | 2.53 |
| 2023-06-30 | $959k | 144k | 6.66 |
| 2023-03-31 | $3.1M | 164k | 18.66 |
| 2022-12-31 | $1.1M | 53k | 21.48 |
| 2022-06-30 | $959k | 73k | 13.20 |
| 2022-03-31 | $1.4M | 69k | 20.90 |
| 2021-12-31 | $1.0M | 50k | 20.33 |
| 2021-09-30 | $1.1M | 36k | 30.32 |
| 2021-03-31 | $5.5M | 127k | 43.16 |
| 2020-12-31 | $12M | 251k | 46.20 |
| 2020-09-30 | $6.5M | 151k | 43.36 |
| 2020-06-30 | $5.3M | 100k | 53.01 |
| 2018-06-30 | $98k | 11k | 9.23 |
| 2018-03-31 | $285k | 28k | 10.22 |